Ontology highlight
ABSTRACT:
INSTRUMENT(S): Q Exactive
ORGANISM(S): Mycobacterium Smegmatis Str. Mc2 155 (ncbitaxon:246196)
SUBMITTER: Jonathan M Blackburn
PROVIDER: MSV000083589 | MassIVE | Mon Mar 18 06:09:00 GMT 2019
SECONDARY ACCESSION(S): PXD004197
REPOSITORIES: MassIVE
Scientific reports 20170306
In the last 40 years only one new antitubercular drug has been approved, whilst resistance to current drugs, including rifampicin, is spreading. Here, we used the model organism Mycobacterium smegmatis to study mechanisms of phenotypic mycobacterial resistance, employing quantitative mass spectrometry-based proteomics to investigate the temporal effects of sub-lethal concentrations of rifampicin on the mycobacterial proteome at time-points corresponding to early response, onset of bacteriostasis ...[more]